Latest Thalidomide Stories
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma.
BioPlus Specialty Pharmacy, one of the nationâ€™s leading specialty pharmacies, offers numerous oncology drugs as well as an oncology therapy management program that increases patient compliance. Altamonte Springs, FL (PRWEB) June 13, 2011 BioPlus Specialty Pharmacy (BioPlus), one of the nationâ€™s leading specialty pharmacies, has numerous oral oncology medications available for patients with cancer.
INDIANAPOLIS, May 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
New research in the FASEB Journal details the first evidence that breakdown products of thalidomide produce the specific, toxic effects of thalidomide in embryos.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.